Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL von Schrader, A., Crispatzu, G., Oberbeck, S., Mayer, P., Pützer, S., von Jan, J., Vasyutina, E., Warner, K., Weit, N., Pflug, N., Braun, T., Andersson, E. I., Yadav, B., Riabinska, A., Maurer, B., Ventura Ferreira, M. S., Beier, F., Altmüller, J., Lanasa, M., Herling, C. D., Haferlach, T., Stilgenbauer, S., Hopfinger, G., Peifer, M., Brümmendorf, T. H., Nürnberg, P., Elenitoba-Johnson, K. S. J., Zha, S., Hallek, M., Moriggl, R., Reinhardt, H. C., Stern, M.-H., Mustjoki, S., Newrzela, S., Frommolt, P., Herling, M.

Volltext

Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine von Pützer, S., Varghese, L., von Jan, J., Braun, T., Giri, A. K., Mayer, P., Riet, N., Timonen, S., Oberbeck, S., Kuusanmäki, H., Mustjoki, S., Stern, M.-H., Aittokallio, T., Newrzela, S., Schrader, A., Herling, M.

Volltext

Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia von Bellanger, D, Jacquemin, V, Chopin, M, Pierron, G, Bernard, O A, Ghysdael, J, Stern, M-H

Volltext

MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor von Franzetti, G-A, Laud-Duval, K, Bellanger, D, Stern, M-H, Sastre-Garau, X, Delattre, O

Volltext

Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations von Golmard, L, Delnatte, C, Laugé, A, Moncoutier, V, Lefol, C, Abidallah, K, Tenreiro, H, Copigny, F, Giraudeau, M, Guy, C, Barbaroux, C, Amorim, G, Briaux, A, Guibert, V, Tarabeux, J, Caputo, S, Collet, A, Gesta, P, Ingster, O, Stern, M-H, Rouleau, E, de Pauw, A, Gauthier-Villars, M, Buecher, B, Bézieau, S, Stoppa-Lyonnet, D, Houdayer, C

Volltext

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling von Andersson, E I, Pützer, S, Yadav, B, Dufva, O, Khan, S, He, L, Sellner, L, Schrader, A, Crispatzu, G, Oleś, M, Zhang, H, Adnan-Awad, S, Lagström, S, Bellanger, D, Mpindi, J P, Eldfors, S, Pemovska, T, Pietarinen, P, Lauhio, A, Tomska, K, Cuesta-Mateos, C, Faber, E, Koschmieder, S, Brümmendorf, T H, Kytölä, S, Savolainen, E-R, Siitonen, T, Ellonen, P, Kallioniemi, O, Wennerberg, K, Ding, W, Stern, M-H, Huber, W, Anders, S, Tang, J, Aittokallio, T, Zenz, T, Herling, M, Mustjoki, S

Volltext

Corrections: Reinstated p53 response and high anti-T-cell leukemia activity by the novel alkylating deacetylase inhibitor tinostamustine von Pützer, S., Varghese, L., von Jan, J., Braun, T., Giri, A. K., Mayer, P., Riet, N., Timonen, S., Oberbeck, S., Kuusanmäki, H., Mustjoki, S., Stern, M.-H., Aittokallio, T., Newrzela, S., Schrader, A., Herling, M.

Volltext

A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages von Gentien, D, Kosmider, O, Nguyen-Khac, F, Albaud, B, Rapinat, A, Dumont, A G, Damm, F, Popova, T, Marais, R, Fontenay, M, Roman-Roman, S, Bernard, O A, Stern, M-H

Volltext

Genetic landscape of uveal melanoma von Rodrigues, M.J., Stern, M.-H.

Volltext

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199) von Patel, V M, Balakrishnan, K, Douglas, M, Tibbitts, T, Xu, E Y, Kutok, J L, Ayers, M, Sarkar, A, Guerrieri, R, Wierda, W G, O'Brien, S, Jain, N, Stern, H M, Gandhi, V

Volltext

Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations von Yuan, W, Stawiski, E, Janakiraman, V, Chan, E, Durinck, S, Edgar, K A, Kljavin, N M, Rivers, C S, Gnad, F, Roose-Girma, M, Haverty, P M, Fedorowicz, G, Heldens, S, Soriano, R H, Zhang, Z, Wallin, J J, Johnson, L, Merchant, M, Modrusan, Z, Stern, H M, Seshagiri, S

Volltext

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model von Couronné, Lucile, Scourzic, Laurianne, Pilati, Camilla, Della Valle, Véronique, Duffourd, Yannis, Solary, Eric, Vainchenker, William, Merlio, Jean-Philippe, Beylot-Barry, Marie, Damm, Frederik, Stern, Marc-Henri, Gaulard, Philippe, Lamant, Laurence, Delabesse, Eric, Merle-Beral, Hélène, Nguyen-Khac, Florence, Fontenay, Michaëla, Tilly, Hervé, Bastard, Christian, Zucman-Rossi, Jessica, Bernard, Olivier A, Mercher, Thomas

Volltext

Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial von Bidard, F.-C., Ychou, M., Madic, J., Saliou, A., Bouché, O., Rivoire, M., Ghiringhelli, F., Francois, E., Guimbaud, R., Mineur, L., Khemissa-Akouz, F., Mazard, T., Moussata, D., Cacheux, W., Proudhon, C., Stern, M.-H., Pierga, J.-Y., Stanbury, T., Thezenas, S., Mariani, P.

Volltext

Patient-specific circulating tumor DNA detection during neoadjuvant chemotherapy in triple negative breast cancer von Pierga, J.-Y., Riva, F., Houy, A., Saliou, A., Madic, J., Rampanou, A., Hego, C., Milder, M., Cottu, P., Sablin, M.-P., Vincent-Salomon, A., Lantz, O., Stern, M.-H., Proudhon, C., Bidard, F.-C.

Volltext

Multiple Tumor-Suppressor Gene 1 Inactivation Is the Most Frequent Genetic Alteration in T-Cell Acute Lymphoblastic Leukemia von Cayuela, Jean-Michel, Madani, Ali, Sanhes, Laurence, Stern, Marc-Henri, Sigaux, François

Volltext

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage von Alsafadi, Samar, Houy, Alexandre, Battistella, Aude, Popova, Tatiana, Wassef, Michel, Henry, Emilie, Tirode, Franck, Constantinou, Angelos, Piperno-Neumann, Sophie, Roman-Roman, Sergio, Dutertre, Martin, Stern, Marc-Henri

Volltext

Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations von Yuan, W, Stawiski, E, Janakiraman, V, Chan, E, Durinck, S, Edgar, K A, Kljavin, N M, Rivers, C S, Gnad, F, Roose-Girma, M, Haverty, P M, Fedorowicz, G, Heldens, S, Soriano, R H, Zhang, Z, Wallin, J J, Johnson, L, Merchant, M, Modrusan, Z, Stern, H M, Seshagiri, S

Volltext

Abstract P2-05-09: Withdrawn von Popova, T, Manie, E, Stern, M-H

Volltext

Inactivation of the ATM gene in T-cell prolymphocytic leukemias von STOPPA-LYONNET, D, SOULIER, J, LAUGE, A, DASTOT, H, GARAND, R, SIGAUX, F, STERN, M.-H

Volltext

Hybrid T cell receptor genes formed by interlocus recombination in normal and ataxia-telangiectasia lymphocytes von LIPKOWITZ, S, STERN, M.-H, KIRSCH, I. R

Volltext